Clinical trial / 2013
Seaweed fucoidan supplementation increased influenza vaccine antibody responses in older adults.
A randomized, double-blind, placebo-controlled trial tested 300 mg/day of Mekabu fucoidan versus placebo for 4 weeks before trivalent influenza vaccination in 70 older Japanese adults. The fucoidan group developed higher antibody titers against all three vaccine strains. Antibody increases against the B strain met licensure criteria in the fucoidan group (geometric mean titer ratio 2.4) but not placebo (1.7).
- Study type
- Randomized controlled trial
- Who was studied
- 70 adults over 60 years of age, Japan
- What was measured
- Post-vaccination antibody titers and natural killer cell activity
THE PAPER
Supplementation of elderly Japanese men and women with fucoidan from seaweed increases immune responses to seasonal influenza vaccination.
Negishi H, Mori M, Mori H, Yamori Y. J Nutr, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.